Cite
HARVARD Citation
Dodagatta-Marri, E. et al. (2019). Α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas. Journal for immunotherapy of cancer. 7 (1), p. . [Online].